Screening for hepatocellular carcinoma

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) currently has the fifth highest incidence rate among tumors worldwide, a rate expected to continue to increase over the next several decades. The majority of patients with HCC have cirrhosis of the liver, with chronic hepatitis B and C as the major agents of etiology. Despite advances in technology, the prognosis of patients with HCC has shown little improvement over time, most likely because most patients are diagnosed at advanced stages. HCC meets the criteria established by the World Health Organization for performing surveillance in those at risk for developing this tumor (ie, patients with cirrhosis of the liver). The objective of surveillance is to use a relatively simple and inexpensive examination in a large number of individuals to determine whether or not they are likely to develop cancer, with the overall goal of reducing morbidity and mortality from the cancer. In this article, we evaluate the criteria for performing surveillance for HCC and review the data on the efficacy of current surveillance programs.

Original languageEnglish (US)
Pages (from-to)201-208
Number of pages8
JournalGastroenterology and Hepatology
Volume4
Issue number3
StatePublished - Mar 2008

Fingerprint

Hepatocellular Carcinoma
Liver Cirrhosis
Neoplasms
Chronic Hepatitis B
Chronic Hepatitis C
Technology
Morbidity
Mortality
Incidence

Keywords

  • Detection
  • Diagnosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular carcinoma
  • Liver cancer

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Screening for hepatocellular carcinoma. / Singal, Amit; Marrero, Jorge A.

In: Gastroenterology and Hepatology, Vol. 4, No. 3, 03.2008, p. 201-208.

Research output: Contribution to journalArticle

@article{ca89c8e2d36c4c4aa0fa87f0417d1cc0,
title = "Screening for hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) currently has the fifth highest incidence rate among tumors worldwide, a rate expected to continue to increase over the next several decades. The majority of patients with HCC have cirrhosis of the liver, with chronic hepatitis B and C as the major agents of etiology. Despite advances in technology, the prognosis of patients with HCC has shown little improvement over time, most likely because most patients are diagnosed at advanced stages. HCC meets the criteria established by the World Health Organization for performing surveillance in those at risk for developing this tumor (ie, patients with cirrhosis of the liver). The objective of surveillance is to use a relatively simple and inexpensive examination in a large number of individuals to determine whether or not they are likely to develop cancer, with the overall goal of reducing morbidity and mortality from the cancer. In this article, we evaluate the criteria for performing surveillance for HCC and review the data on the efficacy of current surveillance programs.",
keywords = "Detection, Diagnosis, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Liver cancer",
author = "Amit Singal and Marrero, {Jorge A.}",
year = "2008",
month = "3",
language = "English (US)",
volume = "4",
pages = "201--208",
journal = "Gastroenterology and Hepatology",
issn = "1554-7914",
publisher = "Gastro-Hep Communications, Inc.",
number = "3",

}

TY - JOUR

T1 - Screening for hepatocellular carcinoma

AU - Singal, Amit

AU - Marrero, Jorge A.

PY - 2008/3

Y1 - 2008/3

N2 - Hepatocellular carcinoma (HCC) currently has the fifth highest incidence rate among tumors worldwide, a rate expected to continue to increase over the next several decades. The majority of patients with HCC have cirrhosis of the liver, with chronic hepatitis B and C as the major agents of etiology. Despite advances in technology, the prognosis of patients with HCC has shown little improvement over time, most likely because most patients are diagnosed at advanced stages. HCC meets the criteria established by the World Health Organization for performing surveillance in those at risk for developing this tumor (ie, patients with cirrhosis of the liver). The objective of surveillance is to use a relatively simple and inexpensive examination in a large number of individuals to determine whether or not they are likely to develop cancer, with the overall goal of reducing morbidity and mortality from the cancer. In this article, we evaluate the criteria for performing surveillance for HCC and review the data on the efficacy of current surveillance programs.

AB - Hepatocellular carcinoma (HCC) currently has the fifth highest incidence rate among tumors worldwide, a rate expected to continue to increase over the next several decades. The majority of patients with HCC have cirrhosis of the liver, with chronic hepatitis B and C as the major agents of etiology. Despite advances in technology, the prognosis of patients with HCC has shown little improvement over time, most likely because most patients are diagnosed at advanced stages. HCC meets the criteria established by the World Health Organization for performing surveillance in those at risk for developing this tumor (ie, patients with cirrhosis of the liver). The objective of surveillance is to use a relatively simple and inexpensive examination in a large number of individuals to determine whether or not they are likely to develop cancer, with the overall goal of reducing morbidity and mortality from the cancer. In this article, we evaluate the criteria for performing surveillance for HCC and review the data on the efficacy of current surveillance programs.

KW - Detection

KW - Diagnosis

KW - Hepatitis B

KW - Hepatitis C

KW - Hepatocellular carcinoma

KW - Liver cancer

UR - http://www.scopus.com/inward/record.url?scp=42549156520&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42549156520&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 201

EP - 208

JO - Gastroenterology and Hepatology

JF - Gastroenterology and Hepatology

SN - 1554-7914

IS - 3

ER -